Please assess the completion status of the following clinical trial:

Trial Title: RCT Comparing EVLA Versus Polidocanol Foam in the Treatment of SSV Insufficiency

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* symptomatic varicose veins (CEAP C2s-C6)~* underlying isolated SSV incompetence (SSV reflux time\>0.5sec on duplex ultrasound (DUS))~* reflux involving at least 15 cm of proximal SSV~* minimal SSV diameter of 4 mm at mid-calf (luminal diameter in standing position)~Exclusion Criteria:~* SSV treatment in the preceding 3 months~* post-thrombotic disease~* deep or superficial vein thrombosis of less than 3 months duration~* coexistent ipsilateral GSV insufficiency~* morbid obesity (BMI\>40)~* presence of significant arterial disease (ABPI\<0.5)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ultrasound-guided-foam sclerotherapy (UGFS) (Type: ACTIVE_COMPARATOR): Injection of Polidocanol foam into SSV
- Endovenous Laser Ablation (EVLA) (Type: ACTIVE_COMPARATOR): Ablation of SSV using laser energy

Based on this trial design, predict the completion outcome and termination type (if applicable).